Younger Americans Benefited Less From Booster Shots Than Older People
Among those under age 50, vaccination even without a booster protected strongly against hospitalization and death.. Read Article
Among those under age 50, vaccination even without a booster protected strongly against hospitalization and death.. Read Article
Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one. Read Article
Two reports released Thursday show that people who get booster doses of Johnson & Johnson’s Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of coronavirus, the company said. Read Article
After the vaccine received emergency use authorization this year, he turned to the Provincetown outbreak and Omicron. Plus, recognizing the unsung heroes of vaccine production. Read Article
The hospital’s researchers are part of a global effort to understand the fast-spreading variant. Read Article
“Our data really puts a different perspective on the Provincetown cohort,” said Dan Barouch. Read Article
“Breakthrough infections are not rare, and they’re not unexpected, and they’re not very concerning,” said Dan Barouch. Read Article
Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Read Article
The shots, given two months apart, can offer 94% protection against infections. Read Article
Health care workers and nursing home residents are first in line Read Article

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
